Fluidigm said this week that Patrick Jones has been appointed to the company's board of directors and will chair the board's audit committee.
Jones has been a private investor in Fluidigm since March 2001. He currently sits on the boards of several public companies, including Epocrates, Novell, Lattice Semiconductor, and Openwave Systems.
Jones fills a vacancy created by the resignation of Jeremy Loh, who is a vice president of investments at San Francisco Centre for EDB Investments in Singapore.
Cepheid this week said that Glenn Steele, Jr., has been nominated for election to the company's board of directors.
Steele has been president and CEO of Geisenger Health System since 2001. Prior to that, he was a professor of surgery, vice president for medical affairs, and dean of biology and the Pritzker School of Medicine at the University of Chicago. Steele has also served as professor of surgery at Harvard Medical School; president and CEO of Deaconess Professional Practice Group; and chairman of surgery at New England Deaconess Hospital.
Exact Sciences this week announced the appointment of John Krayacich as senior vice president of sales and marketing.
Krayacich was most recently president and CEO of startups Ambrose Pharmaceuticals and Marinus Pharmaceuticals. Prior to joining Marinus, Krayacich was vice president and therapeutic area head of neuroscience global project management at Novartis.
Krayacich has also worked for Pfizer and Parke-Davis. He holds a BS, MS, and MBA from the University of Western Ontario.
GenMark Diagnostics said this week that it has appointed Paul Ross as Chief Financial Officer.
Ross joins the company from Teledata Technology Solutions, a global information technology consulting service firm. Prior to that, he served as CFO for Mead Instruments and Power-One. Ross also has worked for BP/Atlantic Richfield and PricewaterhouseCoopers.
Ross received a BA from the University of California, Los Angeles; and an MBA from the University of Southern California.